Related Party Transactions (Details) |
3 Months Ended | 6 Months Ended | |||||
|---|---|---|---|---|---|---|---|
|
Feb. 07, 2024
USD ($)
|
Jun. 01, 2022
ILS (₪)
shares
|
Jun. 30, 2026
USD ($)
shares
|
Jun. 30, 2025
USD ($)
shares
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
Dec. 31, 2025
USD ($)
|
|
| Related Party Transactions [Line Items] | |||||||
| Accrued executive salaries | $ 239,539 | $ 239,539 | $ 122,819 | ||||
| Granted with options to purchase (in Shares) | shares | |||||||
| Exchanged for options to purchase of common stock (in Shares) | shares | 9,597,675 | ||||||
| Cash fee | $ 2,500 | ||||||
| Reimbursement amount | $ 500 | ||||||
| General and administrative expenses | $ 344,997 | $ 391,494 | 723,781 | $ 705,123 | |||
| Accrued expense | 4,557 | 4,557 | $ 3,605 | ||||
| Director [Member] | |||||||
| Related Party Transactions [Line Items] | |||||||
| Granted with options to purchase (in Shares) | shares | 2,610 | ||||||
| Mr. Englander [Member] | |||||||
| Related Party Transactions [Line Items] | |||||||
| Cash fee (in New Shekels) | ₪ | ₪ 3,500 | ||||||
| Consulting Agreement [Member] | |||||||
| Related Party Transactions [Line Items] | |||||||
| General and administrative expenses | $ 12,200 | $ 9,866 | $ 23,499 | $ 19,360 | |||
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after reimbursement and fee waiver, of expense for generation of investment income classified as operating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cash outflow for fees classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Change in number of shares issued and outstanding as a result of capital structure change to a stock dividend, stock split or reserve split occurring after the balance sheet date but prior to the later of the issuance of financial statements or the effective date of registration statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|